SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-04-077766
Filing Date
2004-05-04
Accepted
2004-05-04 14:01:57
Documents
4
Period of Report
2003-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A d10ka.htm 10-K/A 27038
2 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 6118
3 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 6144
4 CERTIFICATION OF CEO AND CFO PURSUANT TO SECTION 906 dex320.htm EX-32.0 4578
  Complete submission text file 0001193125-04-077766.txt   46007
Mailing Address 707 EAGLEVIEW BOULEVARD SUITE 414 EXTON PA 19341
Business Address 707 EAGLEVIEW BOULEVARD SUITE 414 EXTON PA 19341 610-458-6200
ANTARES PHARMA INC (Filer) CIK: 0001016169 (see all company filings)

IRS No.: 411350192 | State of Incorp.: MN | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-20945 | Film No.: 04776855
SIC: 3841 Surgical & Medical Instruments & Apparatus
Assistant Director 10